These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6761633)

  • 1. The pathobiology of lymphocyte transformation.
    Taylor CR
    Pathobiol Annu; 1982; 12():65-84. PubMed ID: 6761633
    [No Abstract]   [Full Text] [Related]  

  • 2. [A lymphoproliferative disorder of T-cell origin with appearances of chronic lymphatic leukemia].
    Thoden van Velzen AH; Bom-van Noorloos AA; Feltkamp-Vroom TM; von dem Borne AE; Melief CJ; Silberbusch J
    Ned Tijdschr Geneeskd; 1979 Dec; 123(51):2172-7. PubMed ID: 317509
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell lymphomas and leukemias of post-thymic differentiation.
    Kadin ME; Said J
    Clin Lab Med; 1988 Mar; 8(1):135-50. PubMed ID: 2896086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic large cell lymphoma and acquired angioedema: a novel association?
    Rossi D; Gaidano G
    Ann Ital Med Int; 2002; 17(3):143-5. PubMed ID: 12402660
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benign and malignant lymphoproliferative processes associated with the murine islet system].
    Freytag G; Kolb-Bachofen V; Kiesel U; Kolb H
    Verh Dtsch Ges Pathol; 1981; 65():255-61. PubMed ID: 6750953
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spectrum of lymphoproliferative diseases].
    Franssila K
    Duodecim; 1989; 105(11):1016-39. PubMed ID: 2666087
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surface markers and clinico-pathological characteristics of lymphoproliferative malignancies (author's transl)].
    Minato K; Shimoyama M
    Rinsho Byori; 1978; 26(3):194-200. PubMed ID: 306459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical manifestations of lymphoproliferative disorders of thymic origin].
    Pintado Cros T
    Sangre (Barc); 1984; 29(4-C):731-40. PubMed ID: 6240122
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double-marker (T + B) lymphocytes in lymphoproliferative diseases].
    Pecze K; Dalmi L; Rák K
    Orv Hetil; 1982 Jun; 123(26):1595-7. PubMed ID: 6981087
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal lymphocyte subsets of X-linked lymphoproliferative syndrome.
    Seeley J; Sakamoto K; Ip SH; Hansen PW; Purtilo DT
    J Immunol; 1981 Dec; 127(6):2618-20. PubMed ID: 6271875
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural killer cell neoplasms.
    Chan JK
    Anat Pathol; 1998; 3():77-145. PubMed ID: 10389582
    [No Abstract]   [Full Text] [Related]  

  • 16. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous CD8+ T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorder.
    Khatri VP; Baiocchi RA; Peng R; Oberkircher AR; Dolce JM; Ward PM; Herzig GP; Caligiuri MA
    J Immunol; 1999 Jul; 163(1):500-6. PubMed ID: 10384154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Typification of the immunoproliferative syndromes].
    Leoni P
    Minerva Med; 1982 Apr; 73(15):911-4. PubMed ID: 6281685
    [No Abstract]   [Full Text] [Related]  

  • 19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical lymphocyte markers: interpretation and indications].
    Preud'homme JL
    Presse Med; 1985 Mar; 14(12):669-71. PubMed ID: 3157960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.